Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patient Perspectives on Social Risk Screening and Documentation in a Dermatology Clinic.

Autor: Wilkerson K; University of California, San Francisco School of Medicine, San Francisco., De Marchis E; Department of Family and Community Medicine, University of California, San Francisco School of Medicine, San Francisco., Rudd N; University of California, San Francisco School of Medicine, San Francisco., Williams JC; University of California, San Francisco School of Medicine, San Francisco., Pantell M; Department of Pediatrics, University of California, San Francisco School of Medicine, San Francisco., Ackerman SL; Department of Social and Behavioral Sciences, School of Nursing, University of California, San Francisco., Amerson EH; Department of Dermatology, University of California, San Francisco School of Medicine, San Francisco.; Department of Dermatology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California., Chang AY; Department of Dermatology, University of California, San Francisco School of Medicine, San Francisco.; Department of Dermatology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California.

Publikováno v: JAMA dermatology [JAMA Dermatol] 2023 Dec 01; Vol. 159 (12), pp. 1346-1358.

Overlap of copper and iron uptake systems in mitochondria in Saccharomyces cerevisiae

Autor: Katherine E. Vest, Jing Wang, Micah G. Gammon, Margaret K. Maynard, Olivia L. White, Jai A. Cobine, Wilkerson K. Mahone, Paul A. Cobine

Publikováno v: Open Biology, Vol 6, Iss 1 (2016)

In Saccharomyces cerevisiae, the mitochondrial carrier family protein Pic2 imports copper into the matrix. Deletion of PIC2 causes defects in mitochondrial copper uptake and copper-dependent growth phenotypes owing to decreased cytochrome c oxidase a

Externí odkaz: https://doaj.org/article/79ccb51be14a4ab58ed0058f903efc3d

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation.

Autor: Patel A; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: ameet.patel@vumc.org., Wilkerson K; Department of Hematology/Oncology, Vanderbilt-Meharry Sickle Cell Center of Excellence, Vanderbilt University Medical Center, Nashville, Tennessee., Chen H; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Sharma D; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Hematology/Oncology, Vanderbilt-Meharry Sickle Cell Center of Excellence, Vanderbilt University Medical Center, Nashville, Tennessee., Byrne M; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Green J; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Sengsayadeth S; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Hematology/Stem Cell Transplant, Veteran Hospital Administration, Nashville, Tennessee., Dholaria B; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Savani B; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Hematology/Stem Cell Transplant, Veteran Hospital Administration, Nashville, Tennessee., Chinratanalab W; Department of Hematology/Stem Cell Transplant, Veteran Hospital Administration, Nashville, Tennessee., Jayani R; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Gatwood K; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee., Engelhardt BG; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Kitko C; Division of Hematology/Oncology and Bone Marrow Transplant, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Connelly J; Division of Hematology/Oncology and Bone Marrow Transplant, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Kassim A; Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Hematology/Oncology, Vanderbilt-Meharry Sickle Cell Center of Excellence, Vanderbilt University Medical Center, Nashville, Tennessee.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2022 May; Vol. 28 (5), pp. 277.e1-277.e6. Date of Electronic Publication: 2022 Feb 15.